Contineum Therapeutics
CTNM
#8352
Rank
ยฃ0.13 B
Marketcap
ยฃ5.21
Share price
4.95%
Change (1 day)
-57.53%
Change (1 year)

Revenue for Contineum Therapeutics (CTNM)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of ยฃ39.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Contineum Therapeutics from 2023 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 ยฃ39.24 M